| Charles Yohannan, MD | |
|
25 N Winfield Rd, Ste 400, Winfield, IL 60190 | |
| (630) 469-9200 | |
| Not Available |
| Full Name | Charles Yohannan |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 16 Years |
| Location | 25 N Winfield Rd, Winfield, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124279864 | NPI | - | NPPES |
| 036128569 | Medicaid | IL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 036128569 (Illinois) | Secondary |
| 208M00000X | Hospitalist | 036128569 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Edward Hospital | Naperville, IL | Hospital |
| Advocate Good Samaritan Hospital | Downers grove, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dupage Medical Group Ltd | 5496667941 | 1209 |
News Archive
Caris Life Sciences today announced the presentation of data from a study in which researchers identified biomarker changes, including key driver mutations, in 89% of metachronous paired glioma tumors, indicating changes in response to therapy as the disease progresses.
Fresenius Medical Care AG & Co. KGaA, the world's largest provider of dialysis products and services, today announced that it has signed an agreement to acquire Gambro's worldwide peritoneal dialysis (PD) business. Gambro has decided to prioritize its investments in the hemodialysis field. Fresenius Medical Care is taking advantage of this opportunity to expand its activities in the homecare market, especially in Europe and Asia-Pacific.
A new report has revealed that the simplification of complex nutritional messages has resulted in grain foods like bread and pasta becoming the ‘scapegoat' for weight gain and bloating, despite ample research to the contrary.
Intezyne today announced it has received notification the European Patent Office intends to grant a patent covering a key element of Intezyne's breakthrough drug delivery technology, the IVECT Method. At the core of this technology is the IVECT micelle, a proprietary, polymeric nanoparticle designed to encapsulate and deliver best-in-class therapeutics, while limiting exposure to healthy tissues.
The drug pazopanib may help revolutionize the care of patients with metastatic, rapidly progressive differentiated thyroid cancers, say researchers at Mayo Clinic who are publishing findings of a phase II clinical trial in The Lancet Oncology.
› Verified 9 days ago
| Entity Name | Dupage Medical Group Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801833983 PECOS PAC ID: 5496667941 Enrollment ID: O20031110000535 |
News Archive
Caris Life Sciences today announced the presentation of data from a study in which researchers identified biomarker changes, including key driver mutations, in 89% of metachronous paired glioma tumors, indicating changes in response to therapy as the disease progresses.
Fresenius Medical Care AG & Co. KGaA, the world's largest provider of dialysis products and services, today announced that it has signed an agreement to acquire Gambro's worldwide peritoneal dialysis (PD) business. Gambro has decided to prioritize its investments in the hemodialysis field. Fresenius Medical Care is taking advantage of this opportunity to expand its activities in the homecare market, especially in Europe and Asia-Pacific.
A new report has revealed that the simplification of complex nutritional messages has resulted in grain foods like bread and pasta becoming the ‘scapegoat' for weight gain and bloating, despite ample research to the contrary.
Intezyne today announced it has received notification the European Patent Office intends to grant a patent covering a key element of Intezyne's breakthrough drug delivery technology, the IVECT Method. At the core of this technology is the IVECT micelle, a proprietary, polymeric nanoparticle designed to encapsulate and deliver best-in-class therapeutics, while limiting exposure to healthy tissues.
The drug pazopanib may help revolutionize the care of patients with metastatic, rapidly progressive differentiated thyroid cancers, say researchers at Mayo Clinic who are publishing findings of a phase II clinical trial in The Lancet Oncology.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Charles Yohannan, MD Po Box 713260, Chicago, IL 60677-1260 Ph: (630) 469-9200 | Charles Yohannan, MD 25 N Winfield Rd, Ste 400, Winfield, IL 60190 Ph: (630) 469-9200 |
News Archive
Caris Life Sciences today announced the presentation of data from a study in which researchers identified biomarker changes, including key driver mutations, in 89% of metachronous paired glioma tumors, indicating changes in response to therapy as the disease progresses.
Fresenius Medical Care AG & Co. KGaA, the world's largest provider of dialysis products and services, today announced that it has signed an agreement to acquire Gambro's worldwide peritoneal dialysis (PD) business. Gambro has decided to prioritize its investments in the hemodialysis field. Fresenius Medical Care is taking advantage of this opportunity to expand its activities in the homecare market, especially in Europe and Asia-Pacific.
A new report has revealed that the simplification of complex nutritional messages has resulted in grain foods like bread and pasta becoming the ‘scapegoat' for weight gain and bloating, despite ample research to the contrary.
Intezyne today announced it has received notification the European Patent Office intends to grant a patent covering a key element of Intezyne's breakthrough drug delivery technology, the IVECT Method. At the core of this technology is the IVECT micelle, a proprietary, polymeric nanoparticle designed to encapsulate and deliver best-in-class therapeutics, while limiting exposure to healthy tissues.
The drug pazopanib may help revolutionize the care of patients with metastatic, rapidly progressive differentiated thyroid cancers, say researchers at Mayo Clinic who are publishing findings of a phase II clinical trial in The Lancet Oncology.
› Verified 9 days ago
Timothy R Long, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 25 N Winfield Rd Ste 400, Winfield, IL 60190 Phone: 630-456-7178 Fax: 630-456-7486 | |
Sarah Jaber, DO Hospitalist Medicare: Medicare Enrolled Practice Location: 25 N Winfield Rd Ste 400, Winfield, IL 60190 Phone: 630-456-7178 Fax: 630-456-7486 | |
Ms. Julia Kochel Hernandez, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 25 N Winfield Rd, Ste 400, Winfield, IL 60190 Phone: 630-469-9200 | |
Lipi Mehul Sekhadia, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 25 N Winfield Rd Ste 400, Winfield, IL 60190 Phone: 630-456-7178 | |
Dr. Nicolai E Hinds, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 25 N Winfield Rd, Winfield, IL 60190 Phone: 630-653-4240 Fax: 630-315-6597 | |
Priya Venkataraman, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 25 N Winfield Rd Ste 400, Winfield, IL 60190 Phone: 630-456-7178 Fax: 630-456-7486 | |
Dr. Sana Sajid Chaudhry, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 25 N Winfield Rd Ste 400, Winfield, IL 60190 Phone: 630-456-7178 Fax: 630-456-7486 |